Tune in as PwC specialists discuss the 2025 healthcare outlook, reflecting on 2024’s significant events and exploring how payers and providers can navigate rising costs, scrutiny, AI advances, and policy shifts with resilience and adaptability.

Topics include:

• Medicare and Medicaid drive industry growth amid rising competition, market exits, M&A, AI adoption, and policy challenges.
• AI's potential to enhance healthcare delivery, improve workforce management, and optimize patient care.
• The care-at-home market is growing rapidly, driven by demand and cost efficiency, but sustainability remains a challenge.
• Encouragement for healthcare organizations to adapt and innovate in response to policy shifts and technological advancements.

Speakers:
Thom Bales, Health Services Leader, PwC
Alena Taylor, Principal, PwC
Ruchita Kewalramani, Principal, PwC
Glenn Hunzinger, Health Industries Leader, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC

Linked materials:

• Next in Health: The 2025 Outlook for Health Services: https://www.pwc.com/us/en/industries/health-industries/library/healthcare-trends.html
• Health Policy and Intelligence Institute: https://www.pwc.com/us/en/industries/health-industries/health-policy-and-intelligence-institute.html

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the 2024 deals landscape and offer a preview of what lies ahead. Topics include:

Key topics include:

• A look back at M&A activity in health industries in 2024
• The challenges and potential impediments that could affect deal volumes in the coming year
• How artificial intelligence and tech innovations are reshaping the volume and nature of healthcare transactions
• Key trends and developments to watch for with emphasis on growth, strategic assessments and regulatory factors

Speakers:
Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC

Linked materials:

• https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html
• https://www.pwc.com/us/en/industries/health-industries/library/pharma-life-sciences-deals-outlook.html

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Tune in as authors of PwC's U.S. Healthcare Climate Survey discuss key findings and provide insights into understanding healthcare organizations' responses to climate change, the integration of climate strategies, and the challenges faced in implementation.

Key topics include:

• The survey's background, focus, and objectives that address the prioritization of climate strategies by healthcare organizations in response to climate change impacts
• Differences in climate strategy approaches across sectors, reveals significant disparities in priorities and operational needs amongst payers, providers, pharmaceutical, and medtech companies
• Key statistics and insights on organizational behavior and perceptions related to climate strategy integration, sustainability, and the impact on human health
• Considerations for healthcare stakeholders to enhance climate strategy implementation and address the evolving needs of diverse communities affected by climate change

Speakers:
Mackenzie Daly, Partner, PwC
Stacie Gitkin, Director, PwC
Jenny Colapietro, Consulting Commercial Leader, PwC

Linked materials:
https://www.pwc.com/us/en/industries/health-industries/library/impact-of-climate-change-on-human-health.html

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.